Comparison between Concord Biotech IPO and Utkarsh Small Finance Bank IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Utkarsh Small Finance Bank IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the Utkarsh Small Finance Bank IPO is up to ₹500.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Utkarsh Small Finance Bank IPO is ₹25.00 per share.
| Concord Biotech IPO | Utkarsh Small Finance Bank IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹23.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹25.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹25.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | ₹0.00 per share |
| Market Lot Size | 20 shares | 600 shares |
| Fresh Issue Size | 0 shares | 20,00,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹500.00 Cr |
| OFS Issue Size | 2,09,25,652 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,09,25,652 shares | 20,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹500.00 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while Utkarsh Small Finance Bank IPO opens on Jul 12, 2023. The closing date of Concord Biotech IPO and Utkarsh Small Finance Bank IPO is Aug 08, 2023, and Jul 14, 2023, respectively.
| Concord Biotech IPO | Utkarsh Small Finance Bank IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Jul 11, 2023 |
| Issue Open | Aug 04, 2023 | Jul 12, 2023 |
| Issue Close | Aug 08, 2023 | Jul 14, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Jul 19, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Jul 20, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Jul 21, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Jul 21, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Aug 18, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Oct 17, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to Utkarsh Small Finance Bank IPO P/E ratio of 6.78.
| Concord Biotech IPO | Utkarsh Small Finance Bank IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 84.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 69.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 6.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹2739.76 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 22.64% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 8.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹4.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 20.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in Utkarsh Small Finance Bank IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 5,94,00,000 shares in Utkarsh Small Finance Bank IPO.
| Concord Biotech IPO | Utkarsh Small Finance Bank IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 8,91,00,000 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 5,94,00,000 shares |
| NII | 31,37,348 shares | 2,97,00,000 shares |
| RII | 73,20,479 shares | 1,98,00,000 shares |
| Employee | 10,000 shares | 20,00,000 shares |
| Others | ||
| Total | 2,09,25,652 shares | 20,00,00,000 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas Utkarsh Small Finance Bank IPO subscribed 110.77x.
| Concord Biotech IPO | Utkarsh Small Finance Bank IPO | |
|---|---|---|
| QIB (times) | 67.67x | 135.71x |
| NII (times) | 16.99x | 88.74x |
| Big NII (times) | 19.30x | 91.83x |
| Small NII (times) | 12.37x | 82.57x |
| RII (times) | 3.78x | 78.38x |
| Employee (times) | 24.48x | 18.02x |
| Other (times) | ||
| Total (times) | 24.87x | 110.77x |
